Enovis Corporation (ENOV)
| Market Cap | 3.60B |
| Revenue (ttm) | 4.00B |
| Net Income (ttm) | 67.65M |
| Shares Out | 54.03M |
| EPS (ttm) | 1.37 |
| PE Ratio | 48.75 |
| Forward PE | 13.21 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 395,102 |
| Open | 64.97 |
| Previous Close | 63.44 |
| Day's Range | 64.80 - 66.85 |
| 52-Week Range | 59.15 - 94.10 |
| Beta | 2.12 |
| Analysts | Buy |
| Price Target | 140.35 (+110.5%) |
| Earnings Date | May 10, 2022 |
About ENOV
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therap...
Financial Performance
In 2021, Enovis's revenue was $3.85 billion, an increase of 25.52% compared to the previous year's $3.07 billion. Earnings were $71.66 million, an increase of 68.11%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for ENOV stock is "Buy." The 12-month stock price forecast is 140.35, which is an increase of 110.45% from the latest price.
News
Enovis (ENOV) Tops Q1 Earnings and Revenue Estimates
Enovis (ENOV) delivered earnings and revenue surprises of 8.82% and 177.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Enovis Announces First Quarter 2022 Adjusted Stand Alone Results
Wilmington, DE, May 10, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, today announced its adjuste...
New Strong Sell Stocks for May 5th
ENOV, FFIV, and CABGY have been added to the Zacks Rank #5 (Strong Sell) List on May 5, 2022
Analysts Estimate Enovis (ENOV) to Report a Decline in Earnings: What to Look Out for
Enovis (ENOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Enovis Schedules First Quarter 2022 Earnings Release and Conference Call
Wilmington, DE, April 14, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, today announced that it w...
Enovis (formerly Colfax) Completes Spin-off of ESAB Corporation
Wilmington, DE, April 05, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (“Enovis” or the “Company”) (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporatio...
ESAB Set to Join S&P MidCap 400; PROG Holdings to Join S&P SmallCap 600
NEW YORK , March 30, 2022 /PRNewswire/ -- ESAB Corp. (NYSE: ESAB) will be added to the S&P MidCap 400 effective prior to the opening of trading on Tuesday, April 5. Effective prior to the opening of tra...
Colfax Announces Board of Directors for Post-Spinoff ESAB
Wilmington, DE, March 28, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company which will renamed Enovis Corporation (“Enovis”) following the expected April ...
Why Is Colfax (CFX) Down 4.2% Since Last Earnings Report?
Colfax (CFX) reported earnings 30 days ago. What's next for the stock?
KeyBanc, Morgan Stanley Slash Price Target On Colfax
Colfax Corp's (NYSE: CFX) price target has been lowered to $52 (an upside of 41%) from $60 by KeyBanc analyst Jeffrey Hammond, following ESAB/Enovis's 2022 Investor Day to reflect broadly lower peer mul...
Colfax Announces Expected Completion Date of April 4, 2022 for Spin-Off of ESAB Corporation
Wilmington DE,, March 14, 2022 (GLOBE NEWSWIRE) -- —Colfax Corporation (“Colfax”) (NYSE: CFX) today announced that its Board of Directors has declared (a) a pro rata distribution of 90% of the outstandi...
Colfax Announces Board of Directors for Enovis, the Post-Spinoff Medical Technology Company
Wilmington DE,, March 11, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced the future composition of the Board of Directors (the “Board”...
Colfax Announces Conditional Redemption of its 3.250% Senior Notes due 2025 and its 6.375% Senior Notes due 2026
Wilmington, DE, March 07, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that it had given notice of its i...
Colfax (CFX) Q4 Earnings & Revenues Surpass Estimates, Up Y/Y
Colfax's (CFX) fourth-quarter 2021 net sales increase 23.6% year over year on impressive performance across its segments.
Colfax (CFX) Beats Q4 Earnings and Revenue Estimates
Colfax (CFX) delivered earnings and revenue surprises of 3.51% and 2.15%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
DJO® Showcases Growing Foot & Ankle Portfolio at ACFAS Scientific Conference
DALLAS--(BUSINESS WIRE)-- #acfas--DJO®, a leading global provider of medical technologies, announced it will showcase their growing Foot & Ankle offerings at ACFAS 2022.
Colfax Corporation Announces Fourth Quarter and Full Year 2021 Results
Wilmington, DE, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the fourth quarter and fiscal year ...
Colfax (CFX) Exhibits Strong Prospects, Headwinds Persist
Colfax (CFX) is poised to benefit from its exposure in diverse end markets, acquired assets and solid demand for its products. However, rising costs and high debt levels remain concerns.
Colfax (CFX) Earnings Expected to Grow: Should You Buy?
Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colfax Schedules Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call
Wilmington DE, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results ...
Colfax's (CFX) Product Strength Aids Amid Cost & Supply Woes
Colfax (CFX) benefits from solid product offerings and focus on innovation, healthy demand and acquisition synergies. Cost inflation and supply-chain woes are concerning.
Colfax to Present at the 40th Annual JP Morgan Healthcare Conference
Wilmington, DE, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, announced today that it will be presenting at the J.P. Morgan Healthcare Confe...
Loop Capital Is Bullish On Lincoln Electric; Initiates Colfax With Hold
Loop Capital analyst Chris Dankert initiated coverage of two Machinery companies.
Colfax Announces Plans for Reverse Stock Split
WILMINGTON, DE, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that it plans to hold a special me...
Colfax (CFX) Meets Earnings Estimates in Q3, Lowers View
Colfax's (CFX) Q3 earnings reflect the impacts of improved sales, margin expansion, supply-chain woes and logistics issues. For 2021, it lowers earnings projections on high taxes and pandemic woes.